Charts suggest the euro could see a ‘swift rally’ and lift the market with it, says Jim Cramer

Charts suggest the euro could see a ‘swift rally’ and lift the market with it, says Jim Cramer


CNBC’s Jim Cramer on Wednesday said that the euro could rise in value in the near future, relying on analysis from DeCarley Trading technician Carley Garner.

“The charts, as interpreted by Carley Garner, suggest that the euro’s ready to rebound — if not now then very soon — and I wouldn’t be surprised if she’s right and it helps take the whole stock market up with it,” he said.

The U.S. dollar and euro on Tuesday reached parity, or the same worth, for the first time in 20 years. While the U.S. dollar index has been on the rise, the euro zone’s energy supply crisis and economic problems have put pressure on the euro’s value.

To explain Garner’s analysis, Cramer first examined the monthly chart of the euro-to-dollar exchange rate over the last two decades.

While the euro was trading at $1.60 in early 2008, it has stayed between $1.05 and $1.20 for most of the last ten years, Cramer said. He added that Garner believes the current sell-off is noteworthy, since the currency typically doesn’t dip below $1.03.

“With so [many] traders trying to push the euro down. … She wouldn’t be surprised if there’s one last probe down to crush the remaining bulls before the thing can bottom and start rallying,” he said.

That means the euro could briefly touch 97 or 98 cents compared to the U.S. dollar, according to Cramer.

“Once the narrative shifts, Garner’s predicting a swift rally. Back in 2017, the euro dipped below $1.05 … but within a year it was back to above [$1.25],” he added.

For more analysis, watch Cramer’s full explanation below.



Source

Hershey says GLP-1s are driving higher gum and mint sales
Business

Hershey says GLP-1s are driving higher gum and mint sales

Packages of Ice Breakers spearmint mints Mints are displayed at a Costco Wholesale store on April 27, 2025 in San Diego, California. Kevin Carter | Getty Images Hershey is seeing higher sales for its mints and gum — thanks to the growing use of GLP-1 drugs. “We’ve also seen strong demand for gum and mints, […]

Read More
More than 20,000 people are taking Eli Lilly’s weight loss pill Foundayo, CEO says
Business

More than 20,000 people are taking Eli Lilly’s weight loss pill Foundayo, CEO says

More than 20,000 people have started taking Eli Lilly‘s GLP-1 pill Foundayo in its first few weeks on the market, Lilly CEO Dave Ricks told CNBC on Thursday. The FDA approved Lilly’s once-daily pill Foundayo earlier this month, making it the second oral GLP-1 drug behind Novo Nordisk’s Wegovy pill. Investors have been closely tracking […]

Read More
Lawyers to the wealthy warn that AI legal advice comes with serious risks
Business

Lawyers to the wealthy warn that AI legal advice comes with serious risks

Displeased couple having problems during a meeting with their agent in the office. Skynesher | E+ | Getty Images A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. Lawyer Tasha Dickinson said […]

Read More